Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial - Concepedia

Concepedia

Publication | Open Access

Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial

DOI Full Paper Access

44

Citations

45

References

2022

Year

Rebecca H. Haberman, Katrina A MacFarlane, Sydney Catron, Jonathan Samuels, Rebecca B. Blank, Michael Toprover, Zakwan Uddin, Jiyuan Hu, Rochelle Castillo, Cinty Gong,

Abstract

NCT05004727.

References

	Year	Citations

Page 1